Market Cap 451.10M
Revenue (ttm) 135.16M
Net Income (ttm) -122.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -90.49%
Debt to Equity Ratio 0.00
Volume 540,591
Avg Vol 1,292,540
Day's Range N/A - N/A
Shares Out 53.83M
Stochastic %K 48%
Beta -0.03
Analysts Sell
Price Target $23.14

Company Profile

Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States. Its product pipeline include Prasinezumab, an investigational humanized monoclonal antibody which is in phase 2b clinical trial, as well as phase 1 and 2 clinical trials for the treatment of parkinson's disease and other synucleinopathies. The company also develops Coramitug, an investigational antib...

Industry: Biotechnology
Sector: Healthcare
Phone: 353 1 236 2500
Fax: 353 1 902 3510
Address:
77 Sir John Rogerson’s Quay, Block C Grand Canal Docklands, Dublin, Ireland
Newtimmy
Newtimmy Aug. 27 at 5:48 PM
$PRTA Something knows somebody
0 · Reply
Newtimmy
Newtimmy Aug. 25 at 4:06 PM
$PRTA added some at 8.46… LFG
0 · Reply
Tradermane
Tradermane Aug. 21 at 5:12 PM
0 · Reply
Guptasulo
Guptasulo Aug. 21 at 4:58 PM
$CGTX $LLY $RHHBY $BIIB $PRTA Sharing again for those who are not familiar as to why CGTX stands far apart from the rest. CGTX received highest funding NIA/NIH. Sponsor ACTC(gold standard) selects partners rigorously based on merit. Others (monoclonal or oral) slow down AD over 12-18 months and that too between 25-49%. CGTX over 26 weeks, slows AD by 95%, is unprecedented. CGTX has Key Opinion Leaders, none other has as many peer reviewed articles. Potential to reverse AD. (None other is even close) What does FDA think about the ph2 trial results? CGTX trial over 6 months trial which no other has ever received. Next Ph3 trial for DLB(with BTD) Partnership followed by two trials for AD and DLB. (probably to run in tandem)
0 · Reply
Swing22
Swing22 Aug. 20 at 4:29 PM
$PRTA breaking out of the BATMAN pattern
0 · Reply
BiodegradableShxt
BiodegradableShxt Aug. 19 at 2:22 PM
$PRTA Lets go boys!
0 · Reply
Newtimmy
Newtimmy Aug. 18 at 1:49 AM
$PRTA good week to plow up to $10
0 · Reply
AIIAAIIA_88
AIIAAIIA_88 Aug. 17 at 7:13 PM
$PRTA “Further, researchers reported that superagers’ brains tend to develop few or zero amyloid plaques and tau tangles, which are two tell-tale signs of Alzheimer’s disease. While no specific cause has been determined, researchers believe they are a bit closer to understanding dementia.” PRTA is by far the only leading authority on amyloid plaques and tau tangles research for AD! 🔥🚀🔥🚀🔥🚀🔥🚀🔥🚀🔥
0 · Reply
AIIAAIIA_88
AIIAAIIA_88 Aug. 16 at 6:20 PM
$PRTA A study that began in the year 2000 is finally paying off. Northwestern University's SuperAger program has been in the works for over 25 years, and a new report in the Journal of the Alzheimer's Association is detailing what the group has found. The brain — particularly the cerebral cortex — naturally thins as a person ages, but Northwestern's report shows that may happen less quickly in some people than in others. "It appears that cortical thinning is unavoidable," the report states, "but that it is probably much slower in superagers." Further, researchers reported that superagers' brains tend to develop few or zero amyloid plaques and tau tangles, which are two tell-tale signs of Alzheimer's disease. While no specific cause has been determined, researchers believe they're a bit closer to understanding dementia.
0 · Reply
AIIAAIIA_88
AIIAAIIA_88 Aug. 15 at 1:48 PM
$PRTA Somone bet big on the $7.5 puts (more than 26K contracts) that are expiring today. Wow. Perhaps they thought Roche, Novo Nordisk, and Bristol Myers will all abandon PRTA partnership? LOL
0 · Reply
Latest News on PRTA
Prothena Announces Corporate Restructuring

Jun 18, 2025, 4:05 PM EDT - 2 months ago

Prothena Announces Corporate Restructuring


Why Is Prothena Stock Trading Lower On Tuesday?

May 27, 2025, 7:43 AM EDT - 3 months ago

Why Is Prothena Stock Trading Lower On Tuesday?


Prothena Corporation plc (PRTA) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 8:45 PM EST - 6 months ago

Prothena Corporation plc (PRTA) Q4 2024 Earnings Call Transcript


Prothena Announces Board of Directors Update

Dec 30, 2024, 4:05 PM EST - 8 months ago

Prothena Announces Board of Directors Update


Prothena Announces Leadership Team Updates

Sep 27, 2024, 4:05 PM EDT - 11 months ago

Prothena Announces Leadership Team Updates


Prothena to Participate in Upcoming Healthcare Conferences

Aug 29, 2024, 4:05 PM EDT - 1 year ago

Prothena to Participate in Upcoming Healthcare Conferences


Prothena: Alzheimer's Data Update In 2024 Could Move The Needle

Feb 23, 2024, 12:31 PM EST - 1 year ago

Prothena: Alzheimer's Data Update In 2024 Could Move The Needle


Prothena prepares for potential sale - Bloomberg News

Oct 16, 2023, 11:57 AM EDT - 2 years ago

Prothena prepares for potential sale - Bloomberg News


Prothena: Dunn Appointment And Bristol Opt-In Boost Validation

Jul 27, 2023, 7:23 AM EDT - 2 years ago

Prothena: Dunn Appointment And Bristol Opt-In Boost Validation


Newtimmy
Newtimmy Aug. 27 at 5:48 PM
$PRTA Something knows somebody
0 · Reply
Newtimmy
Newtimmy Aug. 25 at 4:06 PM
$PRTA added some at 8.46… LFG
0 · Reply
Tradermane
Tradermane Aug. 21 at 5:12 PM
0 · Reply
Guptasulo
Guptasulo Aug. 21 at 4:58 PM
$CGTX $LLY $RHHBY $BIIB $PRTA Sharing again for those who are not familiar as to why CGTX stands far apart from the rest. CGTX received highest funding NIA/NIH. Sponsor ACTC(gold standard) selects partners rigorously based on merit. Others (monoclonal or oral) slow down AD over 12-18 months and that too between 25-49%. CGTX over 26 weeks, slows AD by 95%, is unprecedented. CGTX has Key Opinion Leaders, none other has as many peer reviewed articles. Potential to reverse AD. (None other is even close) What does FDA think about the ph2 trial results? CGTX trial over 6 months trial which no other has ever received. Next Ph3 trial for DLB(with BTD) Partnership followed by two trials for AD and DLB. (probably to run in tandem)
0 · Reply
Swing22
Swing22 Aug. 20 at 4:29 PM
$PRTA breaking out of the BATMAN pattern
0 · Reply
BiodegradableShxt
BiodegradableShxt Aug. 19 at 2:22 PM
$PRTA Lets go boys!
0 · Reply
Newtimmy
Newtimmy Aug. 18 at 1:49 AM
$PRTA good week to plow up to $10
0 · Reply
AIIAAIIA_88
AIIAAIIA_88 Aug. 17 at 7:13 PM
$PRTA “Further, researchers reported that superagers’ brains tend to develop few or zero amyloid plaques and tau tangles, which are two tell-tale signs of Alzheimer’s disease. While no specific cause has been determined, researchers believe they are a bit closer to understanding dementia.” PRTA is by far the only leading authority on amyloid plaques and tau tangles research for AD! 🔥🚀🔥🚀🔥🚀🔥🚀🔥🚀🔥
0 · Reply
AIIAAIIA_88
AIIAAIIA_88 Aug. 16 at 6:20 PM
$PRTA A study that began in the year 2000 is finally paying off. Northwestern University's SuperAger program has been in the works for over 25 years, and a new report in the Journal of the Alzheimer's Association is detailing what the group has found. The brain — particularly the cerebral cortex — naturally thins as a person ages, but Northwestern's report shows that may happen less quickly in some people than in others. "It appears that cortical thinning is unavoidable," the report states, "but that it is probably much slower in superagers." Further, researchers reported that superagers' brains tend to develop few or zero amyloid plaques and tau tangles, which are two tell-tale signs of Alzheimer's disease. While no specific cause has been determined, researchers believe they're a bit closer to understanding dementia.
0 · Reply
AIIAAIIA_88
AIIAAIIA_88 Aug. 15 at 1:48 PM
$PRTA Somone bet big on the $7.5 puts (more than 26K contracts) that are expiring today. Wow. Perhaps they thought Roche, Novo Nordisk, and Bristol Myers will all abandon PRTA partnership? LOL
0 · Reply
sepsis74
sepsis74 Aug. 14 at 12:32 AM
$PRTA looks like EcoR1 sold at the low.
1 · Reply
Newtimmy
Newtimmy Aug. 13 at 2:45 PM
0 · Reply
AIIAAIIA_88
AIIAAIIA_88 Aug. 11 at 11:21 PM
$PRTA Ready to POP and ROCKET! 🔥🚀🔥🚀🔥🚀🔥🚀🔥🚀🔥 JMO
0 · Reply
AIIAAIIA_88
AIIAAIIA_88 Aug. 7 at 2:00 PM
$PRTA LOL Trying to kill 7.5 calls with low volume. Let them try. It may hang around 7.5 for a while but AD data are coming! 🚀🚀🚀🔥🔥🔥🚀🚀🚀
1 · Reply
Swing22
Swing22 Aug. 7 at 11:26 AM
$PRTA goin back to 15 fast
0 · Reply
AIIAAIIA_88
AIIAAIIA_88 Aug. 6 at 7:13 PM
0 · Reply
AIIAAIIA_88
AIIAAIIA_88 Aug. 6 at 7:12 PM
$PRTA Short sellers were driving this down into the ground. Even with today’s P3 news from Novo Nordisk, the MC is about $370M which is the net cash level. The Novo deal is for PRTA to receive $1.2B upon successful P3. That is only from the announced P3 drug for Amyloid. The real potential is the AD vaccine and PD drug that will also be in P3 with Roche. The short sellers were betting on $0. What a stupid bunch. LMAO
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 6 at 5:29 PM
Novo Nordisk Commits To Advancing Prothena Corp-Developed Drug Into Late Stage Trial: Retail Turns Hopeful $PRTA $NVO https://stocktwits.com/news/equity/markets/novo-nordisk-commits-to-advancing-prothena-corp-developed-drug-into-late-stage-trial/chrSdM5Rd5l
0 · Reply
stocks271
stocks271 Aug. 6 at 3:04 PM
$PRTA looking good. Ripe for squeeze
0 · Reply
AIIAAIIA_88
AIIAAIIA_88 Aug. 6 at 3:04 PM
$PRTA If the AD vaccine data show potentially good efficacy, this will be the meme stock of all history of mankind. LOL JMO 🔥🚀🔥🚀🔥🚀🔥🚀🔥🚀🔥🚀🔥🚀
0 · Reply
AIIAAIIA_88
AIIAAIIA_88 Aug. 6 at 2:37 PM
$PRTA 🔥🚀🔥🚀🔥🚀🔥🚀🔥🚀
0 · Reply
MonkeyMan24
MonkeyMan24 Aug. 6 at 2:31 PM
0 · Reply